Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract.
To be therapeutically active, oral hyperimmune bovine immunoglobulin concentrate (BIC) must survive its passage through the intestinal tract. This led us to study the gastrointestinal stability of orally administered BIC directed against Clostridium difficile toxins (BIC-C. difficile). BIC-C. diffic...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1997
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163695/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9021173/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.2.236 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
